Loading...

Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis

Objective. To compare the efficacy and tolerability of tofacitinib, an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), as monotherapy and combined with disease-modifying antirheumatic drugs (DMARDs) versus biological DMARDs (bDMARDs) and other novel DMARDs for second-line...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Rheumatol
Main Authors: Bergrath, Evelien, Gerber, Robert A., Gruben, David, Lukic, Tatjana, Makin, Charles, Wallenstein, Gene
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362710/
https://ncbi.nlm.nih.gov/pubmed/28377787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8417249
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!